• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Up1.64% Nasdaq Up1.86%

    Immunomedics Inc. (IMMU)

    -NasdaqGM
    2.25 Up 0.07(3.21%) Jun 29, 4:00PM EDT
    |After Hours : 2.25 0.00 (0.00%) Jun 29, 4:22PM EDT
    Income StatementGet Income Statement for:
    View: Annual Data | Quarterly DataAll numbers in thousands
    Period EndingMar 31, 2016Dec 31, 2015Sep 30, 2015Jun 30, 2015
    Total Revenue 899   671   731   2,396  
    Cost of Revenue338  65  58  47  
    Gross Profit 561   607   673   2,349  
    Operating Expenses
    Research Development13,299  14,262  12,913  11,594  
    Selling General and Administrative1,829  2,043  1,868  1,943  
    Non Recurring -   -   -   -  
    Others -   -   -   -  
    Total Operating Expenses -   -   -   -  
    Operating Income or Loss (14,567) (15,698) (14,108) (11,188)
    Income from Continuing Operations
    Total Other Income/Expenses Net43  91  81  146  
    Earnings Before Interest And Taxes(14,523)(15,607)(14,027)(11,041)
    Interest Expense1,370  1,370  1,370  1,370  
    Income Before Tax(15,893)(16,977)(15,397)(12,411)
    Income Tax Expense(1,872)(3,204)19  16  
    Minority Interest26  27  22  27  
    Net Income From Continuing Ops(13,996)(13,746)(15,394)(12,401)
    Non-recurring Events
    Discontinued Operations -   -   -   -  
    Extraordinary Items -   -   -   -  
    Effect Of Accounting Changes -   -   -   -  
    Other Items -   -   -   -  
    Net Income (13,996) (13,746) (15,394) (12,401)
    Preferred Stock And Other Adjustments -   -   -   -  
    Net Income Applicable To Common Shares (13,996) (13,746) (15,394) (12,401)

    Sign Up for a Free Trial to EDGAR Online Premium!
    Get the critical business and financial information you need for more than 15,000 U.S. public companies.
    Sign Up Now - Learn More

    Currency in USD.